Genome-wide association studies of late-onset Alzheimer’s disease risk predicted OAS1, LAPTM5, ITGAM/CD11b and LILRB4 as four new risk genes for this neurodegenerative disease. This evidence concerns the gene LAPTM5 and Alzheimer disease.